Drug factory · FDA FEI 3010923869
Auro Peptides Limited
Survey No. 71 & 72, 4th Floor, Indrakaran Village, Kandi Mandal, Sangareddy District, India
No problems found at FDA's last inspection, Feb 16, 2024.
No Action Indicated: inspectors found no objectionable conditions.
2 drug inspections on record since 2016: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Icatibant | Makes the active ingredient and tests it | AuroMedics Pharma LLC | 55150-351 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 16, 2024 | No problems found | Drug Quality Assurance | — |
| Sep 2, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.